Answers are grounded in this paper and cite their sources.
Paraneoplastic syndromes denote rare but notable phenomena caused by the tumour mediated release of bioactive substances. Peptide and non-peptide hormone causes are explored with a particular focus on pathogenesis, symptoms, diagnosis and treatment. Early detection and management of paraneoplastic syndromes can improve morbidly and mortality; definitive treatment remains effective surgical or anti-tumour therapies. Pituitary autoimmunity may provide a novel presentation of paraneoplastic syndromes for which further research is warranted.
No takes yet. Share an insight, caveat, or question.
Onyema et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: